(Q40948889)

25 September 2017

Contractile responses to prostacyclin (PGI2) of isolated human saphenous and rat venous tissue (English)

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90205-8

7 April 2023

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90205-8

7 April 2023

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90205-8

7 April 2023

author name string

J. V. Levy

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A360301

7 April 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=360301

7 April 2023

publication date

1 July 1978

1 reference

full work available at URL

25 September 2017

https://api.elsevier.com/content/article/PII:0090698078902058?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90205-8

https://api.elsevier.com/content/article/PII:0090698078902058?httpAccept=text/plain

7 April 2023

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90205-8

7 April 2023

1 reference

25 September 2017

16

1 reference

25 September 2017

1

1 reference

25 September 2017

93-97

1 reference

Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation

25 September 2017

1

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90205-8

Prostacyclin (PGX) is the endogenous metabolite responsible for relaxation of coronary arteries induced by arachindonic acid

7 April 2023

2

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90205-8

The effects of prostacyclin (PGI2) on tissues which detect prostaglandins (PG'S)

7 April 2023

3

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90205-8

Prostacyclin (PGI2) is a weak contractor of coronary arteries of the pig

7 April 2023

4

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90205-8

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

7 April 2023

5

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90205-8

Effect of synthetic bradykinin on contractile tension of human saphenous vein strips

7 April 2023

6

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90205-8

Prostacyclin-like activity in rat vascular tissues. fast, long-lasting inhibition by treatment with lysine acetylsalicylate

7 April 2023

12

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90205-8

Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation

7 April 2023

13

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90205-8

Prostacyclin, a potent vasodepressor in primates

7 April 2023

14

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90205-8

Cardiovascular responses to PGI2 (prostacyclin) in the dog

7 April 2023

15

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90205-8

Comparison of the vasodepressor effects of prostacyclin and 6-oxo-prostaglandin F1alpha with those of prostaglandin E2 in rats and rabbits

7 April 2023

16

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90205-8

7 April 2023

Identifiers

1 reference

25 September 2017

1 reference